216 related articles for article (PubMed ID: 35064619)
1. TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.
Khalil MI; Singh V; King J; De Benedetti A
Mol Oncol; 2022 Jul; 16(13):2537-2557. PubMed ID: 35064619
[TBL] [Abstract][Full Text] [Related]
2. The TLK1-MK5 Axis Regulates Motility, Invasion, and Metastasis of Prostate Cancer Cells.
Khalil MI; De Benedetti A
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497211
[TBL] [Abstract][Full Text] [Related]
3. Targeting Prostate Cancer, the 'Tousled Way'.
Bhoir S; De Benedetti A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446279
[TBL] [Abstract][Full Text] [Related]
4. Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance.
Khalil MI; De Benedetti A
Cancer Drug Resist; 2022; 5(1):93-101. PubMed ID: 35582542
[TBL] [Abstract][Full Text] [Related]
5. The TLK1-Nek1 axis promotes prostate cancer progression.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Cancer Lett; 2019 Jul; 453():131-141. PubMed ID: 30928383
[TBL] [Abstract][Full Text] [Related]
6. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
[TBL] [Abstract][Full Text] [Related]
7. The Ser(186) phospho-acceptor site within ERK4 is essential for its ability to interact with and activate PRAK/MK5.
Perander M; Aberg E; Johansen B; Dreyer B; Guldvik IJ; Outzen H; Keyse SM; Seternes OM
Biochem J; 2008 May; 411(3):613-22. PubMed ID: 18248330
[TBL] [Abstract][Full Text] [Related]
8. NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output.
Khalil MI; Ghosh I; Singh V; Chen J; Zhu H; De Benedetti A
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297404
[TBL] [Abstract][Full Text] [Related]
9. New insights into the activation, interaction partners and possible functions of MK5/PRAK.
Perander M; Keyse SM; Seternes OM
Front Biosci (Landmark Ed); 2016 Jan; 21(2):374-84. PubMed ID: 26709779
[TBL] [Abstract][Full Text] [Related]
10. Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Int J Cancer; 2019 Aug; 145(4):1055-1067. PubMed ID: 30737777
[TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK.
Ronkina N; Johansen C; Bohlmann L; Lafera J; Menon MB; Tiedje C; Laaß K; Turk BE; Iversen L; Kotlyarov A; Gaestel M
PLoS One; 2015; 10(8):e0136138. PubMed ID: 26295581
[TBL] [Abstract][Full Text] [Related]
12. Tousled-like kinase 1 promotes gastric cancer progression by regulating the tumor growth factor-beta signaling pathway.
Sun RC; Li J; Li YX; Wang HZ; Dal E; Wang ML; Li YX
World J Gastroenterol; 2023 Nov; 29(44):5919-5934. PubMed ID: 38111505
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of heat shock protein 40 (Hsp40/DnaJB1) by mitogen-activated protein kinase-activated protein kinase 5 (MK5/PRAK).
Kostenko S; Jensen KL; Moens U
Int J Biochem Cell Biol; 2014 Feb; 47():29-37. PubMed ID: 24309468
[TBL] [Abstract][Full Text] [Related]
14. Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.
Khalil MI; Madere C; Ghosh I; Adam RM; De Benedetti A
Pathophysiology; 2021 Jul; 28(3):339-354. PubMed ID: 35366279
[TBL] [Abstract][Full Text] [Related]
15. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
[TBL] [Abstract][Full Text] [Related]
16. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1.
Singh V; Khalil MI; De Benedetti A
Cell Cycle; 2020 Feb; 19(3):363-375. PubMed ID: 31914854
[TBL] [Abstract][Full Text] [Related]
17. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart.
Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058
[TBL] [Abstract][Full Text] [Related]
18. Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination.
Shi Y; Kotlyarov A; Laabeta K; Gruber AD; Butt E; Marcus K; Meyer HE; Friedrich A; Volk HD; Gaestel M
Mol Cell Biol; 2003 Nov; 23(21):7732-41. PubMed ID: 14560018
[TBL] [Abstract][Full Text] [Related]
19. Does MK5 reconcile classical and atypical MAP kinases?
Perander M; Keyse SM; Seternes OM
Front Biosci; 2008 May; 13():4617-24. PubMed ID: 18508533
[TBL] [Abstract][Full Text] [Related]
20. The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.
Brand F; Schumacher S; Kant S; Menon MB; Simon R; Turgeon B; Britsch S; Meloche S; Gaestel M; Kotlyarov A
Mol Cell Biol; 2012 Jul; 32(13):2467-78. PubMed ID: 22508986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
